Target Information
Target General Information | Top | |||||
---|---|---|---|---|---|---|
Target ID |
T97725
|
|||||
Target Name |
Virus Replication (Viru Repli)
|
|||||
Gene Name |
NO-GeName
|
|||||
Target Type |
Clinical trial target
|
[1] | ||||
Disease | [+] 1 Target-related Diseases | + | ||||
1 | Common warts [ICD-11: 1E80] | |||||
UniProt ID |
Drugs and Modes of Action | Top | |||||
---|---|---|---|---|---|---|
Clinical Trial Drug(s) | [+] 3 Clinical Trial Drugs | + | ||||
1 | CLS006 | Drug Info | Phase 3 | Verruca vulgaris | [1] | |
2 | BTL-TML-001 | Drug Info | Phase 2 | Influenza virus infection | [2] | |
3 | CLS003 | Drug Info | Phase 2 | Plantar wart | [1] | |
Mode of Action | [+] 1 Modes of Action | + | ||||
Inhibitor | [+] 3 Inhibitor drugs | + | ||||
1 | CLS006 | Drug Info | [1] | |||
2 | BTL-TML-001 | Drug Info | [1] | |||
3 | CLS003 | Drug Info | [1] |
References | Top | |||||
---|---|---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||||
REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800031551) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.